Table 1 |
|||||
|
The correlation between the expression of BCRP and the clinicopathological parameter |
|||||
|
Patients |
BCRP expression |
P value |
|||
|
|
|||||
|
n (%) |
negative |
low |
high |
||
|
|
|||||
|
Age |
0.801 |
||||
|
|
|||||
|
≤ 50 years |
80 |
10 |
38 |
32 |
|
|
|
|||||
|
> 50 years |
116 |
16 |
59 |
41 |
|
|
|
|||||
|
Histology-type |
0.711 |
||||
|
|
|||||
|
IDC |
155 |
20 |
75 |
60 |
|
|
|
|||||
|
IDC with others |
41 |
6 |
22 |
13 |
|
|
|
|||||
|
Histology-grade |
0.424 |
||||
|
|
|||||
|
G1/G2 |
143 |
19 |
67 |
57 |
|
|
|
|||||
|
G3 |
53 |
7 |
30 |
16 |
|
|
|
|||||
|
Tumour size |
0.210 |
||||
|
|
|||||
|
≤ 2.0 cm |
97 |
9 |
48 |
40 |
|
|
|
|||||
|
> 2.0 cm |
99 |
17 |
49 |
33 |
|
|
|
|||||
|
LNM |
0.049* |
||||
|
|
|||||
|
- |
103 |
8 |
56 |
39 |
|
|
|
|||||
|
+ |
93 |
18 |
41 |
34 |
|
|
|
|||||
|
ER |
0.136 |
||||
|
|
|||||
|
-/+ |
96 |
14 |
53 |
29 |
|
|
|
|||||
|
++/+++ |
100 |
12 |
44 |
44 |
|
|
|
|||||
|
PR |
0.693 |
||||
|
|
|||||
|
-/+ |
128 |
18 |
65 |
45 |
|
|
|
|||||
|
++/+++ |
68 |
8 |
32 |
28 |
|
|
|
|||||
|
HER2 |
0.001* |
||||
|
|
|||||
|
-/+ |
138 |
18 |
57 |
63 |
|
|
|
|||||
|
++/+++ |
58 |
8 |
40 |
10 |
|
|
|
|||||
|
Ki67 |
0.906 |
||||
|
|
|||||
|
Positive ≤ 50% |
154 |
21 |
75 |
58 |
|
|
|
|||||
|
Positive > 50% |
42 |
5 |
22 |
15 |
|
|
|
|||||
|
Clinical stage |
0.015* |
||||
|
|
|||||
|
Stage I |
60 |
2 |
32 |
26 |
|
|
|
|||||
|
Stage IIa and IIb |
86 |
11 |
44 |
31 |
|
|
|
|||||
|
StageIIIa and IIIb |
50 |
13 |
21 |
16 |
|
|
|
|||||
|
P values were evaluated by chi-square test or the Fisher's exact test. *P < 0.05. |
|||||
|
Xiang et al. Diagnostic Pathology 2011 6:90 doi:10.1186/1746-1596-6-90 |
|||||